바로가기 메뉴
본문 바로가기
메뉴 바로가기
페이지 하단 바로가기

미래 지향적 PIPELINE 설계 창의적 제품 개발 및 최상의 품질 기준을 달성하겠습니다.

R&D Center

R&D center
In 1990, DongKoo attained KGMP (Korea Good Manufacturing Practice), and has built stable pharmaceutical product systems in drug development, purchasing active and inactive pharmaceutical ingredients, quality control, and thorough customer management.

Laboratory

The mission of R&D, DongKoo Bio&Pharma Co., Ltd. is based on the ideal of "life dignity and disease cure"

Since 1970, we are contributing to becoming a corporation in terms of health and happy future life through constant research development providing safe and effective medical products.Through the technical partnership with the advanced pharmaceutical companies of Europe and Japan, introduced "Cernilton" as a safe prostate cure of ingredient of medicinal herbs and " Ventrux" as active probiotic intestinal cure within a country. On the other hand, we devote ourselves on new medical products, improvement of new medicines, and first generic development based on the material technology ourselves.

Paving the new growth power of future through improvement of new medicines

We elevate the effectiveness of the drug as the development of external usage steroids introduced Multi Lamellar Emulsion (MLE), the reproduction technology of skin lipids structure and minimize the side-effect based on absorption of entire body.We build stable R&D pipeline for manufacturing the new medical products and development of regent improved through steady research, the development of improvement of new medicines changed the injection pathway, and the development of DDS product through the release controlling system, and SC development research base specialized based on improvement of non-soluble medicines. Major products are "Alastin Tab. (epinastine)", "Sponex cap. (itraconazole)", "Thermatasone MLE cream(Mometasone Furoate)", "Famclovir ( Famciclovir)", "Uropa tab. (Tamsulosin)" We propel the diversification of the business of the development of medical products, health functional foods ( Ethical foods etc), medical appliances (anti-snoring devices etc), cosmetic (using stem cells), bio-medical products development and etc based on the strong point of skin urology, otorhinolaryngology and expanding to internal medicine. In the future, Dongkoo Bio&Pharma. Co., Ltd. is becoming the leading company of the development of new medical products with all passion that contribute to national health, treatment of disease, and welfare based on the differentiated strategy and technology competitiveness.

Group of research Institute

Central research institute of Dongkoo Bio&Pharma. Co., Ltd. is

It is composed of the team of improvement of new medical products, SC team, team of product research, and team of analysis research. Each team is advanced and has excellent competitiveness.
Also, each team performs the task of manufacturing new medical products, improvement of new medical products, health functional foods, and the development of foods for the differentiated continuous development of technology and enforcing the core ability to provide new growth power through strategic R&D ability.

Central research institute
team of improvement of new medical products
  • Research new medical products
  • Research Bio
  • Research DDS new product
Team of product research
  • ETC generic
  • OTC generic
  • Products for exporting
SC team
  • Research BA improvement dosage form
  • Research health functional foods
team of analysis research
  • Research evalu-ation of materials
  • Research analysis method
  • Research validation